Spotlight
Topic
Brand Insights
Subscribe
- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Pernix Announces New CEO, Senior Management Shake-Up
July 28, 2016
Pernix Therapeutics Holdings (Morristown, NJ) has announced a reorganization of its senior management team, with John Sedor assuming the role of Chief Executive Officer.
The company also appointed Graham Miao as President and Chief Financial Officer, while reporting that Sanjay Patel, Chief Financial Officer, Terence Novak, Chief Operating Officer, and Barry Siegel, Senior Vice President and General Counsel are no longer employed by Pernix.
John Sedor has served as Pernix's interim CEO and Chairman of the Board since May. Prior to this, he served as President, CEO and Director of Cangene Corporation and President, CEO and Director of CPEX Pharmaceuticals.
Recent Videos
Related Content
